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Editorial: Intersections in (new) drug research 




Background context: new drugs 
 
dŚŝƐ ĂƌƚŝĐůĞ ŝƐ ĐŽŶĐĞƌŶĞĚ ǁŝƚŚ ƚŚĞ ƐƚƵĚǇ ŽĨ  ‘ŶĞǁ ĚƌƵŐƐ ? ĂƉƉůǇŝŶŐ Ă ďƌŽĂĚ ĚĞĨŝŶŝƚŝŽŶ ǁŚŝĐŚ
encompasses both New Psychoactive Substances (NPS), the subject of much recent research 
attention, and the comparatively under-explored area of Human Enhancement Drugs (HED).    
The study of new drugs has usually primarily focused on NPS - a catch all term for chemical 
compounds that have been modified and developed to mimic the effects of drugs that are 
already prohibited.  The rise in the range and availability of NPS (Winstock & Ramsey (2010), 
particularly prevalent between 2009 and 2016, has resulted in a prioritization of this area 
amongst national and international government agencies responsible for responding to the 
drugs problem (EMCDDA, 2017; UNODC, 2017).  In particular, they have struggled to 
implement legislative responses to effectively control this phenomenon (Reuter & Pardo, 
2017; Reuter & Pardo, 2016).  It is generally agreed that more knowledge is needed in this 
area, but only a small percentage of the studies conducted to address this issue consider their 
wider socio-political contexts and consequences (see for example, DĞĂƐŚĂŵ ? ? ? ? ? ?K ?ƌŝĞŶ 
et al, 2014; Lauritsen & Rosenberg, 2016).    
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This Special Issue is one of the outcomes of a two-year Economic and Social Research Council 
(ESRC) funded seminar series (RES-000-23-0384) that brought together academics, 
practitioners, policy makers, and service users to examine emerging issues in the area of new 
drugs (https://newdrugseminars.wordpress.com) from a sociological perspective.  The 
seminar series took place between 2014 and 2016, culminating in a conference and 
postgraduate and early career workshop in September 2016 at the University of Kent (UK).  
This was a time when NPS were a rising concern within both UK and global drug policy 
landscapes, creating a climate of rapid drug policy change.  The series comprised seven events 
on various aspects of the field (policy; markets; police and prisons; psychopharmacology; risk; 
harm reduction and community intervention; and future directions) and was underpinned by 
two main aims which set it apart from other NPS related events.  The first was to include a 
wide variety of participants ranging from academics, policy makers, practitioners, law 
enforcement agencies, and the users of new drugs themselves.  The second was a desire to 
study NPS, not in isolation, but in tandem with other new drugs such as HED (e.g. steroids, 
cognitive enhancers, sexual enhancers etc.), and alongside more traditional illegal drugs (e.g. 
heroin, ecstasy/MDMA, cannabis).   
 
Despite the significant research attention that has been given to NPS in recent years, there 
has been less focus on other new drugs (Chatwin et al, 2017) and little appreciation of the 
similarities and differences between them.  Instead, different kinds of new drugs have 
traditionally been studied quite separately. Furthermore, NPS and HED have rarely been 
considered in conjunction with substantial existing bodies of knowledge on more established 
illegal substances.  In our wider seminar series, and within this special issue, the aim has been 
to address this gap in knowledge by explicitly seeking to understand the intersectional 
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complexity of meaning where traditional drugs crossover with new drugs including NPS and 
HED, and where new drugs cross over with each other.  The successful achievement of the 
aims of the seminar series is evidenced by the rich and varied research collated here on the 
intersections in drug research and by the inclusion of an academic and practitioner writing 
partnership (Blackman et al, 2018). 
 
 
Intersections: new drugs and traditional drugs 
The primary unifying theme of our special issue is thus not NPS, or even new drugs, but the 
importance and complexity of these intersections.  We employ the theoretical idea of 
intersection in this special edition because it links together a diversity of different impact 
points in relation to understanding drugs in society and culturĞ ?<ŝŵďĞƌůĠƌĞŶƐŚĂǁ ?Ɛ ? ? ? ?4) 
original argument about intersectionality is that it can reveal forms of coercion and 
discrimination which derive from different aspects of the social structure. For her, 
intersection reflects multiple forms of oppression at a structural level, and here we intend to 
use intersection in a macro sense of the differences between new drug research and the 
ĞǆŝƐƚŝŶŐ ďŽĚǇ ŽĨ ƌĞƐĞĂƌĐŚ ŽŶ  ‘ƚƌĂĚŝƚŝŽŶĂů ? ŝůůĞŐĂů ĚƌƵŐƐ ĂŶĚ ƚŚĞŶ ƚƌĂĐĞ the impact of these 
intersections at a micro level focusing, primarily, on drug users and drug service providers. 
 
Several of the articles contained within this Special Issue focus on intersections as a way to 
provide a sense of the impact which NPS, and the responses to them, have had on existing 
bodies of knowledge about the traditional drugs field.  For example, collective evidence from 
articles concerned with drug-related service delivery, health or law enforcement work more 
widely, or indeed ƚŚĞ  ‘ƉƐǇĐŚŽŶĂƵƚ ? ĚƌƵŐ user, reveal that practitioners and drug users 
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motivated by a desire to use drugs responsibility have all had to readdress and reevaluate 
their strategies in light of the rise of new drugs, their unpredictability and their propensity to 
undermine either professional practice or expert knowledge.   Several of the articles capture 
this experience in qualitative data.  By forefronting research participant voices, these articles 
demonstrate how expertise has been recalibrated, and service delivery developed through 
creative responses, interventions and new styles of work. 
 
In particular, several of the articles have focused on the area of drug service provision as one 
that is particularly worthy of study in an intersectional context.  Drug service practitioners 
have to deal with the day to day reality of substance consumption. Collectively, the papers 
offered here attest to a complex situation catalyzed by the rising profile of new drugs.  On the 
one hand, we need to recognize that many users of new drugs will also be users of other 
substances and thus may already be known to existing service providers, suggesting that 
interventions would most appropriately address underlying problems rather than specific 
substances.  On the other hand, however, we also need to recognize that with new drugs, 
new problems will arise and existing services have to innovate and develop in order to 
effectively address the issue and continue to attract users of all substances to their 
interventions.  This complex and paradoxical situation perfectly illustrate both the deep 
complexities and the inherent value of exploring these intersectional fields.     
 
 
A final key area of intersectional interest emerging from this issue concerns drugs and media 
representations.  This issue was critically addressed by Jock Young (1971: 179) in his classic 
study The Drugtakers, where he ƐƚĂƚĞƐƚŚĞŵĞĚŝĂ “ƐĞůĞĐƚƐĞǀĞŶƚƐǁŚŝĐŚĂƌĞĂƚǇƉŝĐĂů ?presents 
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them in a stereotypical fashion, and contrasts them against a backcloth of normality which is 
overtypical. The atypical is selected because the everyday or humdrum is not interesting to 
read or watch, it has little news value ? ?  Stan Cohen (1972: 9) further contributed to this 
debate, arguing that his key concept of  ‘moral panic ? ŝƐƌĞůĂƚĞĚƚŽĂ “ŐƌŽƵƉŽĨƉĞƌƐŽŶƐ ?ǁŚŽ
ĞŵĞƌŐĞ  “ƚŽďĞĐŽŵĞĚĞĨŝŶĞĚĂƐĂƚŚƌĞĂƚƚŽƐŽĐŝĞƚĂůǀĂůƵĞƐĂŶĚ ŝŶƚĞƌĞƐƚƐ ?, a status that has 
often been conferred on the users of various different illegal substances at different time 
periods since the 1970s.  In this issue, Blackman et al (2018) and Alexandrescu, (2018) pick up 
and further develop these theoretical concepts by exploring the recent designation by the 
ŵĞĚŝĂŽĨh<ƵƐĞƌƐŽĨƐƉŝĐĞĂƐ ‘ǌŽŵďŝĞƐ ? ? Clearly, Zombies are a major threat to the human 
race but they are of course fictional creations of the imagination.  As Cohen (1972) originally 
described, the mass media fashion stereotypes and these stylized  ‘ŵŽŶƐƚĞƌƐ ?ǁŽƌŬŽŶƚŚĞ
imagination of people through a process of mediation.  Rather than use accurate information 
to describe the drug problem, the visual representations produce a fantasy of fear.  We fear 
zombies, and we should fear NPS as it creates zombies.  Anti-drug images have a long history 
within the media and the movies.   
 
Introducing research on intersections in the wider drugs fields and theorising drug use 
 
The final section of this editorial introduces the individual contributions to our Special Issue 
in more detail, teasing out their contribution to the theme of intersections in a more detailed 
manner.  By focusing on specific intersections, Ralphs & Gray (2018) address head on the 
point raised above about the paradox of drug treatment and service provision  ? do we need 
specific services to deal with NPS or other new drugs, or should we rather attempt to adapt 
existing services so they are able to deal with, not only NPS and other new drugs, but also a 
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range of more traditional substances?  Ralphs & Gray present research with two groups of 
vulnerable drug users in Manchester  ? the homeless population and those active on the MSM 
(men who have sex with men)/chemsex scene.  They argue that both scenes have undergone 
a significant shift, from the primary use of more traditional illegal drugs to the primary use of 
NPS.  In the homeless population, this has comprised a move from heroin to Synthetic 
Cannabis Reactor Agents (SCRA), and in the MSM/chemsex scene from the non-intravenous 
use of ecstasy and cocaine to the injection of methamphetamine and mephedrone.  Ralphs & 
Gray ?s research suggests that the number of users of SCRA and 
methamphetamine/mephedrone in these groups who are accessing treatment services are 
worryingly low and explores the reasons why this might be the case.  
 
Ultimately, Ralphs & Gray ?Ɛ ĚŝƐĐƵƐƐŝŽŶ ƚĞĂƐĞƐ ŽƵƚ ƚŚĞ ĐŽŵƉůĞǆŝƚŝĞƐ ĂƌŽƵŶĚ ƚƌĞĂƚŵĞŶƚ ĂŶĚ
service provision in this area.  It argues that some users of newer substances do find it off 
putting that existing services have been designed around people who use heroin and crack 
cocaine.  On the other hand, there are also underlying issues which affect the treatment 
system in general, regardless of which substance is being used.  Examples of these underlying 
factors include the shame and stigma associated with treatment and drug-related services in 
general and the practicalities of accessing services that are only open at certain times and 
only available in certain geographical locations (Blackman & Bradley, 2017).  Ralphs & Gray 
recommend that in order to engage the users of newer substances, we need to adapt existing 
systems by offering training on up to date substance specific information and, at the same 
time, implement new, more innovative, services  ? for example pop-up services that open out 
of hours or services attached to specific locations such as homeless centres or fetish clubs.  
These new services, of course, would have appeal to the users of both new and old drugs, and 
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a final pertinent point raised in this article is that pathways are needed, not only into services, 
but between different services such as treatment, the criminal justice system and mental 
health services. 
 
Echoing these sentiments, but in a different context, Addison et al (2018) have conducted a 
study within a police custody suite which engages with both the individuals who end up in 
police detention with NPS in their system, and the police officers who have to deal with them.  
Focusing on the intersections with other drugs, Addison et al report that NPS users are usually 
users of other substances as well as NPS, and are often already known to the police prior to 
their NPS use.  As with Ralphs & Gray ?ƐƐƚƵĚǇ ?ƚŚŝƐƐƵŐŐĞƐƚƐƚŚĂƚEW^ƐŚŽƵůĚŶŽƚďĞǀŝĞǁĞĚĂƐ
a distinct problem in their own right, but rather as part of a pattern of complex polydrug use 
and other non drug-related issues.  Here again, however, there is a paradox as police 
themselves report that despite this connection between the use of legal and traditional illegal 
drugs, they do feel that NPS have placed an added burden on an overstretched service and 
that more knowledge on new substances is needed if detention is to be used as a time to 
support people in reducing their reliance on these substances. 
 
Blackman et al (2018), writing as an academic and service provider partnership, have also 
conducted research in the service provision setting, this time with professionals working with 
young people across the county of Kent.  They also focus on the inconsistency in strategy 
between substances and between different service agencies, but the main thrust of their 
contribution is to explore the impact NPS have had on driving forward and developing existing 
theories and concepts in the wider drug field. For example, they suggest an increasing sense 
of ambiguity within drug markets, applying DĂƚǌĂ ?Ɛ  ?1964) concept of drift to chart young 
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ƉĞŽƉůĞ ?ƐŵŽǀĞĨƌŽŵŝůůĞŐĂůĚƌƵŐƐ ?ƚŽǁĂƌĚƐEW^ ?ĂŶĚƚŚĞŶďĂĐŬĂŐĂŝŶ ?dŚĞǇĂůƐŽĞǆƉůŽƌĞƚŚĞ
concept of normalisation in the context of emerging critiques that equate normalisation with 
the tolerance of illegal and harmful substances, particularly in the context of NPS.    
Furthermore, they note that providing NPS interventions which aim to reduce the harm 
associated with use has been difficult, and has thus provided a challenge for the application 
of the concept of harm reduction in this area.   Instead they argue for a focus on pragmatic 
ƐƚƌĂƚĞŐŝĞƐƐƵƌƌŽƵŶĚŝŶŐ ‘ƐĞŶƐŝďůĞĚƌƵŐƵƐĞ ? ? an approach which would allow service providers 
to focus on underlying issues such as risk which are not dependent on specific substances.  
 
Blackman et al (2018) provide one example of the benefits brought from considering NPS in 
the wider drugs context, explaining how the advent of NPS has helped to challenge and drive 
forward existing theories and concepts associated with understanding drug use and our 
responses to it. Their arguments sit at the heart of the drug intersectionalities debate 
suggesting that NPS have had an important impact, but they are not an entirely separate 
entity worthy of study, or of service provision, in isolation.  Responding to them, either 
theoretically or practically, does require changes to the existing landscape but, ultimately, 
they are very much a part of the wider drugs field and cannot be properly understood if they 
are not seen as such.   
 
Potter & Chatwin (2018) take up this theme by critically engaging with the validity of the 
construction of the category NPS as distinct in its own right.  They suggest that placing NPS in 
their own distinct category presents three main consequences: the differences within the 
category (i.e. between different kinds of NPS) are obscured; the similarities between NPS and 
other categories (e.g. more traditional drugs, HED) are obscured; and a separation of NPS 
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from the wider field of drugs prevents us from understanding the bigger picture in terms of 
the wider societal, cultural and theoretical underpinnings of drug use.  They argue that these 
consequences are visible across a variety of arenas, for example: public discourse, policy 
making and academic research. 
 
 A practical example of the benefit to studying drugs and drug users in the wider context, 
rather than as members of a specific group related to type of substance used, is provided by 
ZƵĂŶĞ ?Ɛ (2018) qualitative research on psychonauts and the provision of harm reduction 
services at music festivals.  Ruane identifies psychonauts as those who are interested in and 
enjoy experimenting with drugs  ? whether they are new or old.  Her article offers insight into 
the depth of ŚĞƌ ƌĞƐƉŽŶĚĞŶƚƐ ? mistrust of government drug information and of their own 
struggle to retain autonomy and clarity as a result of the availability of an increasingly diverse 
range of drugs.  In her interviews with those involved in this scene, she critiques the category 
ŽĨEW^ŝŶůŝŶĞǁŝƚŚWŽƚƚĞƌ ?ŚĂƚǁŝŶ ?Ɛ(2018) arguments.  Like Blackman et al (2018), she also 
focuses on the challenge NPS have presented for harm reduction services in general and the 
impact her research population are having on   harm reduction efforts in this area.  For 
example, the psychonauts in her study act as sitters/mentors for those undergoing an intense 
drug experience in an unfamiliar environment, some become  ‘ƌĞƐƉŽŶƐŝďůĞ ?ĚĞĂůĞƌƐ ?ŽƌĐŽůůĂƚĞ
ĂŶĚƐŚĂƌĞǀŝĂƚŚĞŝŶƚĞƌŶĞƚƚŚĞŝƌŽǁŶ ‘ƐĐŝĞŶƚŝĨŝĐ ?ƌĞƐĞĂƌĐŚŽŶƚŚĞĞĨĨĞĐƚƐŽĨƚŚĞƉůĞƚŚŽƌĂŽĨŶĞǁ
substances now available on the market.  
 
Koenraadt and van de sĞŶ ?ƐƉĂƉĞƌ (2018) explores internet and lifestyle drugs and, in line 
with Blackman et al (2018), finds the application of normalization theory relevant to the 
understanding of substances (whether for sexual enhancement of weight-loss) as integrally 
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related to individual identity and personal pleasures. A further key finding of the study, 
echoing priorities in wider drug-related research, - is the gender differences inherent in the 
lifestyle drug market in relation to social and cultural pressures, whereby men buy body based 
performance drugs and pain killers whereas female substance use is dominated by weight-
loss drugs.  Perhaps most interestingly, from an intersectionality perspective, however, is the 
implication that focusing explicitly on one particular category of drugs can obscure the 
similarities experienced across categories, and thus impair our overall understandings.  In this 
context, the authors contend that another area of recent research focus has been the 
development of internet markets for illegal drugs, and that this area has been disadvantaged 
by a failure to also consider as part of that development, the semi-legal internet markets that 
exist for lifestyle drugs, and the blurring of the boundaries between them.   
 
&ŝŶĂůůǇ ? ůĞǆĂŶĚƌĞƐĐƵ ?Ɛ  ?2018) article provides a cautionary tale of what will happen if we 
ĚŽŶ ?ƚƵƐĞEW^ĂƐĂŶŝŵƉĞƚƵƐƚŽĚƌŝǀĞĨŽƌǁĂƌĚŶĞǁƵŶĚĞƌƐƚĂŶĚŝŶŐƐ ?His analysis of how the 
Romanian and British mainstream media have reacted to NPS use depicts a depressingly 
familiar picture.  He outlines the bifurcated practice of conceptualising NPS users as either 
good, sober, educated young people unfairly corrupted by dangerous new substances 
available on the market, or as polluted and unsalvageable members of vulnerable populations 
such as the homeless, the mentally ill or the prison population.  In this context, Alexandrescu 
conceptualises NPS as the latest trend in substance use to be seized upon by the media, with 
the negative consequences that can bring.  Ultimately, he argues that the media and the way 
they report on matters are an important driver of policy agendas.   As such, if we want to 
shape NPS policy in more sensible directions and if we want to have meaningful debates and 
pragmatic interventions, rather than knee jerk responses, to this latest chapter in our drug 
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history, then we need to start by reforming the way that drugs and drug users are reported 
on in the media.   
Conclusion 
 
Collectively, these articles attest to the value in focusing on the ways in which different 
categories of drugs (NPS, HED, traditional illegal drugs) intersect with each other, rather than 
studying them in isolation from each other.  Our special issue evidences the various benefits 
that can come from such an approach.  In the more practical arena, the rise of new drugs has 
necessitated drug service providers to move forward and innovate in their response to 
diversifying drug use: for example, by introducing services that are open out of hours and/or 
attached to specific locations, by encouraging pragmatic strategies that focus on underlying 
issues such as risk rather than on the specifics of individual substances, and by creating 
pathways between different agencies of service provision.   Importantly, the impact of many 
of these benefits will also be felt by users of more traditional substances and will help to 
refocus attention on the underlying causes (e.g. poverty, homelessness, imprisonment) of 
drug use amongst vulnerable people, whichever substances are involved. At a more 
theoretical level, not only can many existing drug-related theories and concepts be 
successfully applied to new drugs, the impact of new drugs on existing bodies of knowledge 
(for example in areas such as harm reduction, moral panic theory, and normalization theory) 
can provide a useful catalyst for the further evolution of our understanding.  It is clear that 
further research is needed, not only on new drugs themselves, but also on the ways in which 
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